Learn how restriction site-associated DNA sequencing can help us learn about ecology, evolution, and conservation efforts.
Learn more at:
Illumina HiSeq®: illumina.com/systems/sequencing-platforms/hiseq-2500.html
PMID: 26729255 | Andrews, et al. (2016): ncbi.nlm.nih.gov/pubmed/26729255
PMID: 26715661 | Ali, et al. (2016): ncbi.nlm.nih.gov/pubmed/26715661
The Science Mondays (SciMon) series is brought to you by Illumina illumina.com
Illumina hosts -- Irene Predazzi, Sr Scientific Liaison, Scientific Affairs and Jacques Retief, Associate Director Scientific Affairs -- give you a quick report on breaking news.
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
*Data calculations on file. Illumina, Inc., 2015.
Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc
View customer spotlight videos
View Illumina webinars
View Illumina product videos
View Illumina support videos